About Us



Discovering and Development of Needed Medicines for Tropical Diseases

60° Pharmaceuticals (60P) was founded in 2010 with a mission to discover, develop, and distribute new medicines for treatment and prevention of tropical diseases. Our core business is delivering tropical disease drug research and development while providing an attractive return for investors. 60P has embraced an open innovation approach to reduce the time, cost, and risk needed to build a portfolio of drug discovery and development projects. We collaborate with leading research institutions in the United States, Australia, and Singapore to discover and develop medications for dengue fever and malaria prevention.


Core Team

Geoffrey Dow, PhD, MBA
CEO

Ty Miller, CPA
CFO/Director

Doug Loock
, MBA
VP Commercial Operations

Jennifer Herz
Director

Bryan Smith, MD
CMO


Operations

HQ – Washington, D.C. (USA)
R&D – Australia & Singapore





About  |  Tropical Diseases  |  Products  |  Research  |  Responsibility  |  Investors  |  Media  |  Careers  |  Contact 

 1025 Connecticut Avenue NW, Suite 1000   Washington, DC 20036 
Phone: 1-240-351-1167   Email: inquiries@60degreespharma.com 

 Content © 2017. 60° Pharmaceuticals, LLC. All rights reserved.